QA: NANOVIRICIDES INC. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2021_NANOVIRICIDES_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}

Graph

Absolute values for 0001379006, NANOVIRICIDES INC.

  xvar xval
0 AssetsCurrent 13,985,657
1 IntangibleAssetsNetIncludingGoodwill 358,388
2 PropertyPlantAndEquipmentNet 9,544,431
3 remainder_Assets 25,863
4 LiabilitiesCurrent 2,156,377
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,300,935
9 ResearchAndDevelopmentExpense 4,695,524
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -5,450,079
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 23,914,339
1 Liabilities 2,156,377
2 Expenses 7,996,459
3 Revenues 0
4 StockholdersEquity 21,757,962
5 NetIncome -13,446,538
6 ComprehensiveNetIncome -13,446,538
7 BaseVar 19,758,627
8 EconomicCapitalRatio 1.84

Edgar->Model Mapping

Feature Distribution

Change over Time